$3.47
+0.03 (+0.73%)
Open$3.46
Previous Close$3.45
Day High$3.50
Day Low$3.20
52W High$71.50
52W Low$3.18
Volume—
Avg Volume69.4K
Market Cap6.09M
P/E Ratio—
EPS$-25.77
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+786.7% upside
Current
$3.47
$3.47
Target
$30.77
$30.77
$21.48
$30.77 avg
$35.71
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 18.39M | 59.60M | 759.7K |
| Net Income | -1,407,587,770 | -4,105,084,228 | -24,634 |
| Profit Margin | -7,652.8% | -7,270.1% | -3.2% |
| EBITDA | -1,182,760,510 | -3,641,032,030 | -38,889 |
| Free Cash Flow | — | — | -29,815 |
| Rev Growth | -69.1% | -69.1% | +6.1% |
| Debt/Equity | — | — | 0.67 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |